secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158355
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte shareholders re-elect Class I directors, ratify Deloitte as auditor, approve say-on-pay
--------------------------------------------------------------------------------

- Annie Drapeau re-elected with 82,886,170 votes for; Teri Loxam with 96,840,846; Carlos Paya with 96,685,408.
- Ratification of Deloitte & Touche as auditor for FY 2024: 103,807,993 for, 14,745 against, 24,027 abstain.
- Non-binding advisory vote on executive compensation approved: 91,072,269 for, 7,934,248 against, 23,235 abstain.
- Three Class I directors to serve until 2027 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312524158355/0001193125-24-158355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312524158355/d741791d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer